Andrew Steinsapir

Director, Gene Therapy Program Lead | Acting Chief Technology Officer

Apertura Gene Therapy

April Sena

Vice President - Technical Operations

Life Edit Therapeutics

Ashutosh Gupta

Independent Expert

Aziza Manceur

Research officer and Adjunct professor

National Research Council Canada

Bella Neufeld

Vice President - Operations

Teknova

Clayton Deighan

Sales & Applications Manager

Nano FCM

Dorota Bulik

Senior Director

Ultragenyx Pharmaceutical Inc.

Erin Gilbert

Associate Director, Business Development

Lonza

Hao Liu

Postdoctoral Researcher

UMass Gene Therapy Center

Ishtiaq Khaliq

Lead Gene Therapy Molecular Biology Sciences, Analytical Development Sciences

UCB

Jaymi fallon

sr manager

Takeda Pharmaceutical

Jorge Santiago-Ortiz

Sr Director, CMC

Apertura Gene Therapy

Julia Rohlhill

Associate Director, Viral Vector Sciences

Legend Biotech

Kok Seong Lim

Analytical Sciences & Quality Control Expert

Independent Expert

Matthew Weaver

Vice President - Chemistry, Manufacturing & Controls Development

Spirovant Sciences

Michael Datillo

Senior Investigator, Lentiviral Vector Manufacturing Excellence

Johnson & Johnson

Michael DiBiasio-White

Senior Scientist

Ring Therapeutics

Oleg Shinkazh

Founder & Chief Technology Officer

Chromatan Corporation

Peng Wang

Associate Director, Business Development, Technical Sales, Cell & Gene Therapies

Lonza

Rekha Iyengar

Senior Scientist Vector Development and Manufacturing

Stanford University

Soundarya Kandala

Senior Associate Scientist

Biogen

Valerie Ng

Associate Director, Regulatory CMC

Kite, a Gilead Company

Ying Cai

Executive Director - Manufacturing Sciences & Technology

Ultragenyx Pharmaceutical Inc.

Yuanli Song

AD

Sanofi